Cargando…
CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cells
Targeted cancer therapy concepts often aim at the induction of adjuvant antitumor immunity or stimulation of tumor cell apoptosis. There is further evidence that combined application of immune stimulating and tumor apoptosis-inducing compounds elicits a synergistic antitumor effect. Here, we describ...
Autores principales: | El-Mesery, M, Trebing, J, Schäfer, V, Weisenberger, D, Siegmund, D, Wajant, H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847307/ https://www.ncbi.nlm.nih.gov/pubmed/24232092 http://dx.doi.org/10.1038/cddis.2013.402 |
Ejemplares similares
-
CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants
por: Trebing, J, et al.
Publicado: (2014) -
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020) -
Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018) -
Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022) -
T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv
por: Zhong, Kunhong, et al.
Publicado: (2020)